Big 3 wholesalers to rise with generics; Indian plant shut for polluting;

> Big three drug wholesalers McKesson, Cardinal Health and AmerisourceBergen all are expected to enjoy steep paydays as a result of the coming generic boom. Story

> A pollution control board in India has shut down an Orchid Chemicals & Pharmaceuticals cephalosporin API manufacturing plant for solid waste disposal violations. News

> Phillips Plastics will acquire Medisize, a European provider of design and manufacturing services to pharma, diagnostic and medical device companies. Item

> In Nigeria, the health ministry secretary has challenged pharmaceutical companies to upgrade their facilities and processes to be in line with those required for World Health Organization prequalification. Article

> Developments in nanotechnology and electronic printing are being used to fight counterfeits. Story

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

After months of delay for ultra-pricey gene therapy Zynteglo, Bluebird Bio is hoping to dose its first German patients in the first half of the year.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)